AMR news related to Smart Innovations

For scientists, researchers, and innovators committed to staying at the forefront of antimicrobial resistance, AMR Insights provides the most comprehensive, up-to-date overview of global news and breakthroughs. Access cutting-edge research, expert insights, and the latest developments to fuel your work and accelerate progress in the fight against AMR.


9 March 2023

Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug-resistant Burkholderia multivorans

8 March 2023

ChatGPT and antimicrobial advice: the end of the consulting infection doctor?

8 March 2023

SMART researchers develop novel combination bacterium- and host-targeted therapy for treating vancomycin-resistant bacterial infections

6 March 2023

WHO 2023 data call is now open for antibacterials in the preclinical development pipeline

2 March 2023

Antimicrobial Peptides and Cell-Penetrating Peptides: Non-Antibiotic Membrane-Targeting Strategies Against Bacterial Infections

28 February 2023

Innovate UK KTN Launches Phage Innovation Network

23 February 2023

Doherty researchers develop world-first AMR detection tool 

20 February 2023

Impact funds help fight dementia and antibiotic resistance

19 February 2023

A broad-spectrum synthetic antibiotic that does not evoke bacterial resistance

19 February 2023

Molecular diagnostics for genotypic detection of antibiotic resistance: current landscape and future directions

15 February 2023

Bacteria hide their resistance – a challenge for diagnostics

11 February 2023

NEW CRP: Innovative Nuclear and Related Molecular Approaches for Detection and Characterization of Antimicrobial Resistance in Animal Production Environment

9 February 2023

Metals to combat antimicrobial resistance

8 February 2023

Landscape of Push Funding in Antibiotic Research: Current Status and Way Forward

1 February 2023

Antibacterial Nanomaterials: Mechanisms, Impacts on Antimicrobial Resistance and Design Principles

30 January 2023


Plant toxin hailed as ‘new weapon’ in antibiotic war against bacteria

24 January 2023

Sweet salvation — how a sugar cane pathogen is gearing up a new era of antibiotic discovery

24 January 2023

Adaptive Phage Therapeutics Announces First Patient Dosed in the PHAGE Clinical Trial Evaluating Phage Therapy in Cystic Fibrosis-related Respiratory Infection

24 January 2023

Engineered live bacteria suppress Pseudomonas aeruginosa infection in mouse lung and dissolve endotracheal-tube biofilms

18 January 2023

Development of diagnostic tests for pathogen identification and detection of antimicrobial resistance on WHO global priority pathogens using modular real-time nucleic acid amplification test

17 January 2023

Can the UK ‘Netflix’ Payment Model Boost the Antibacterial Pipeline?

13 January 2023

Scientists discover how bacteria use electrical spikes to tolerate antibiotics

11 January 2023

Broad-impact Tech Against AMR Threat

11 January 2023

Phage therapy: From biological mechanisms to future directions

6 January 2023

Broad-impact Tech Against AMR Threat

6 January 2023

AMR Action Fund Announces Investment in BioVersys AG

5 January 2023

In silico discovering relationship between bacteriophages and antimicrobial resistance

5 January 2023

An ISO-certified genomics workflow for identification and surveillance of antimicrobial resistance

5 January 2023

Perseverant bacteria challenge antibacterial treatment

16 December 2022

Three ways to combat antimicrobial resistance

15 December 2022

Evidence at time of regulatory approval and cost of new antibiotics in 2016-19: cohort study of FDA approved drugs

15 December 2022

Comparison of bacterial suppression by phage cocktails, dual-receptor generalists, and coevolutionarily trained phages

13 December 2022

Web-based Tool Validation for Antimicrobial Resistance Prediction: An Empirical Comparative Analysis

12 December 2022

Self-assembling nanofibrous bacteriophage microgels as sprayable antimicrobials targeting multidrug-resistant bacteria

10 December 2022

AMR Insights curated global online AMR diagnostics developer directory (ADDD) with JPIAMR funded B2B2B AMRDx research network

10 December 2022

Identifying antibiotics based on structural differences in the conserved allostery from mitochondrial heme-copper oxidases

10 December 2022

Self-assembling nanofibrous bacteriophage microgels as sprayable antimicrobials targeting multidrug-resistant bacteria

9 December 2022

Report UK Global Expert Mission Antimicrobial Resistance US 2022

9 December 2022

A need for novel diagnostics: meeting the moment

8 December 2022

IFPMA and AMR Insights enter into Partnership

8 December 2022

Bench, Bedside, Business, and Beyond: innovative solutions for AMR diagnostics (B2B2B AMRDx)

5 December 2022

FDA Approves First Fecal Microbiota Product

2 December 2022

Researchers discover new form of antimicrobial resistance

28 November 2022

Efficacy of phage therapy in preclinical models of bacterial infection: a systematic review and meta-analysis

22 November 2022

Molecular mechanisms of antibiotic resistance revisited

19 November 2022

Phase 1 safety trial of a natural product cocktail with antibacterial activity in human volunteers

16 November 2022

Developing moral AI to support decision-making about antimicrobial use

13 November 2022

Characterization of antibiotic-resistance traits in Akkermansia muciniphila strains of human origin

8 November 2022

In situ, in vivo and in vitro approaches for studying AMR plasmid conjugation in the gut microbiome

8 November 2022

Integrated genomics and proteomics analysis of Paenibacillus peoriae IBSD35 and insights into its antimicrobial characteristics



What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed